An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia
Clinical trial NCT06315283 · COMPLETED
Trial details
- NCT number
- NCT06315283
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-20
- Primary completion
- 2025-08-14
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.